News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (SNY)'s Zika Standoff: Bad Medicine?



8/11/2017 6:43:09 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Sanofi (NYSE: SNY) has had a bumper year thus far. Its revenue has exceeded analysts’ expectations and its share price jumped more than 20% YTD. It has outperformed the S&P 500 as well as the NYSE ARCA Pharmaceutical Index. That performance means Sanofi has successfully dodged the struggles plaguing other pharmaceutical firms after the shenanigans surrounding the late American Health Care Act. But a series of scandals and changing political attitudes have sounded alarm bells for the company’s fortunes.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES